Get Premium to unlock powerful stock data
NAS:INDP (USA)  
Indaptus Therapeutics Inc logo

Indaptus Therapeutics Inc

$ 3.15 +0.02 (+0.64%) 10:08 PM EST
P/E:
At Loss
P/B:
0.77
Market Cap:
$ 26.02M
Enterprise V:
$ -10.18M
Volume:
100.59K
Avg Vol (2M):
696.59K
Volume:
100.59K
Market Cap $:
26.02M
PE Ratio:
At Loss
Avg Vol (2-Month):
696.59K
Enterprise Value $:
-10.18M
PB Ratio:
0.77
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Indaptus Therapeutics Inc
NAICS : 541714 SIC : 2834
3 Columbus Circle, 15th Floor, New York, NY, USA, 10019
Description
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma in standard pre-clinical models.
Name Current Vs Industry Vs History
Cash-To-Debt 244.45
Equity-to-Asset 0.9
Debt-to-EBITDA -0.01
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 88.88
9-Day RSI 77.43
14-Day RSI 68.08
6-1 Month Momentum % -55.76

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.03
Quick Ratio 10.03
Cash Ratio 9.83

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -72.15
ROA % -59.13
ROIC % -606.86
ROC (Joel Greenblatt) % -17295.12
ROCE % -58.47

Financials (Next Earnings Date:2022-08-16 Est.)

INDP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:INDP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -2.984
Beta 0
Volatility % 0
14-Day RSI 68.08
14-Day ATR ($) 0.286729
20-Day SMA ($) 2.3925
12-1 Month Momentum % 0
52-Week Range ($) 1.89 - 28.8299
Shares Outstanding (Mil) 8.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Indaptus Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More